Carol A. Webb

Carol Webb served as president of Ortho Biotech Inc., a Johnson & Johnson company in the U.S., from 1994 to 2000.  She joined the company in 1987 as a product director for PROCRIT® (epoetin alfa), a leading biologic drug that is used for the treatment of anemia associated with cancer chemotherapy, AZT-treated HIV patients, chronic kidney disease patients not on dialysis, and as an alternative to blood transfusions for certain elective surgery patients.  Today, Ms Webb is Company Group Chairman at Johnson & Johnson.  She has global and direct line responsibility in the U.S. and Europe for Ortho Biotech, a member of the Johnson & Johnson family of companies. 

Carol Webb is Company Group Chairman at Johnson & Johnson.  She has global and direct line responsibility in the U.S. and Europe for Ortho Biotech, a member of the Johnson & Johnson family of companies.  She serves on the Johnson & Johnson Pharmaceuticals Group Operating Committee.

Carol served as president of Ortho Biotech Inc., a Johnson & Johnson company in the U.S., from 1994 to 2000.  She joined the company in 1987 as a product director for PROCRIT® (epoetin alfa), a leading biologic drug that is used for the treatment of anemia associated with cancer chemotherapy, AZT-treated HIV patients, chronic kidney disease patients not on dialysis, and as an alternative to blood transfusions for certain elective surgery patients.  Carol was promoted to executive director for Product Management in 1990 and named vice president of Sales and Marketing in 1993.

She currently serves on the Board of Directors of the Biotechnology Council of New Jersey and the Board of Directors of The Cancer Institute of New Jersey.  She is a member of the Access to Quality Cancer Care team for the National Dialogue on Cancer.  She is also an advisor to the Women’s Health and Counseling Center, a United Way agency that provides preventive healthcare and sexual assault support service to under- and un-insured women.

In 1995, Carol was named “Woman of the Year” by the Healthcare Businesswomen’s Association.  She is also a recipient of the Duke University Comprehensive Cancer Center’s “Jonquils” award which is presented each year to distinguished individuals and organizations who have made significant contributions in the fight against cancer.  In May 1998, Carol received the “Human Service Award” from Cancer Care, Inc., a New York-based organization that provides emotional support, information and practical help to people with cancer and their loved ones.  In February 2001, Carol received the Médaille Vermeille de la Ville de Paris from the City of Paris for her outstanding commitment to oncology.

Carol received her B.S. degree in biology from Bowling Green State University and trained as a field zoologist.  She began her professional career as a science teacher in Ohio, then joined Roche Laboratories in 1972 where she held a number of positions including sales representative, sales trainer, product manager and manager of public policy.  In 1983, she switched to medical marketing and worked as an account supervisor for two New York advertising agencies before joining Johnson & Johnson.